These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3093900)

  • 21. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
    Blier P; Bouchard C
    Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum.
    Craig DA; Eglen RM; Walsh LK; Perkins LA; Whiting RL; Clarke DE
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):9-16. PubMed ID: 2402303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ; Green AR
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation by drugs of the release of total tritium and 3H-5-HT from rat hypothalamic slices.
    Moret C; Briley M
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):398-403. PubMed ID: 2366876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydroergocristine-induced stimulation of the 5-HT autoreceptor in the hypothalamus of the rat.
    Moret C; Briley M
    Neuropharmacology; 1986 Feb; 25(2):169-74. PubMed ID: 3010160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
    Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
    Tekes K; Magyar K
    Neurobiology (Bp); 2000; 8(3-4):257-64. PubMed ID: 11225517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of RU 24969 on serotonin release in rat brain cortex: further support for the identity of serotonin autoreceptors with 5-HT1B sites.
    Göthert M; Schlicker E; Fink K; Classen K
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):31-42. PubMed ID: 3662697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P; Youdim MB
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin autoreceptor subsensitivity and antidepressant activity.
    Moret C; Briley M
    Eur J Pharmacol; 1990 May; 180(2-3):351-6. PubMed ID: 2365009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.
    Göthert M; Schlicker E; Kollecker P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):124-30. PubMed ID: 2939353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR; Zreika M; Robin M; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
    Yoneda F; Moto T; Sakae M; Ohde H; Knoll B; Miklya I; Knoll J
    Bioorg Med Chem; 2001 May; 9(5):1197-212. PubMed ID: 11377178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
    Robinson JB
    Biochem Pharmacol; 1985 Dec; 34(23):4105-8. PubMed ID: 3933519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methiothepin enhances the potassium-evoked release of [3H]-noradrenaline in rat pineal gland.
    Taranger MA; Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):374-80. PubMed ID: 2963232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V; Pycock CJ; Sandler M
    Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.